Skip to main content
The muscle and expertise to trailblaze
life-transforming therapies

Dyne was founded with a singular focus: to deliver life-transforming therapies for people living with serious muscle diseases. We are utilizing our proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery and advance modern oligonucleotide therapeutic candidates. We have assembled an exceptional team with deep experience in muscle disease, rare disorders, drug development and manufacturing and commercialization of novel therapeutics. We have also established a scientific advisory board comprised of leading experts in the fields of muscle disease drug discovery and development and nucleic acid therapeutics, who share our mission.

Because together, we are stronger.

Joachim, living with DM1
Joachim, living with DM1

Our leadership team

Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities:

Joshua Brumm picture

Joshua Brumm

President and Chief Executive Officer

Susanna High, MBA picture

Susanna High, MBA

Chief Operating Officer

Wildon Farwell, M.D., MPH picture

Wildon Farwell, M.D., MPH

Chief Medical Officer

Oxana Beskrovnaya, Ph.D. picture

Oxana Beskrovnaya, Ph.D.

Chief Scientific Officer

Ashish Dugar, Ph.D., MBA picture

Ashish Dugar, Ph.D., MBA

Senior Vice President, Global Head of Medical Affairs

Jonathan McNeill, M.D. picture

Jonathan McNeill, M.D.

Senior Vice President, Business Development

Debra Feldman picture

Debra Feldman

Senior Vice President, Head of Regulatory Affairs

John Najim, MBA picture

John Najim, MBA

Senior Vice President, Chemistry, Manufacturing and Controls

Rick Scalzo, MBA picture

Rick Scalzo, MBA

Senior Vice President, Head of Finance & Administration

Amy Reilly picture

Amy Reilly

Senior Vice President, Head of Corporate Communications & Investor Relations

Expanded Leadership team
Card image cap

John Davis, Ph.D.

Vice President, Head of Preclinical Development

Card image cap

Chris Mix, M.D., M.S.

Senior Vice President, Pharmacovigilance

Card image cap

Gene Kim

Vice President, Finance

Card image cap

Molly White

VP, Global Head of Patient Advocacy and Engagement

Card image cap

Daniel Wilson

Vice President, Head of Intellectual Property

Card image cap

Kate Mitchell

Vice President, Head of Human Resources

Card image cap

Bruce Wentworth, Ph.D.

Senior Scientific Advisor

Board of directors

Jason Rhodes

Chairman

Joshua Brumm

Ed Hurwitz

Carlo Incerti

Dirk Kersten

Lawrence Klein

David Lubner

Catherine Stehman-Breen

Scientific advisory board

Sudhir Agrawal, D.Phil.

Nancy Andrews, M.D., Ph.D.

Louis Kunkel, Ph.D.

Francesco Muntoni, FRCPCH, FMedSci

Jeffrey Statland, M.D.

Charles Thornton, M.D.

Contact Us

For general inquiries, email us at info@dyne-tx.com.

To learn more about partnerships or working together, email us at partnerships@dyne-tx.com.

For investor and media inquiries, email us at ir@dyne-tx.com

Follow us on

Offices

1560 Trapelo Road
Waltham, MA 02451
Phone: 781.786.8230
Fax: 781.786.8866